
|Videos|June 1, 2021
Nevakar spins off ophthalmic-only company Vyluma
A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.
Advertisement
Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Simplifying the treatment of ocular surface disease
2
Classifying dry eye by root cause: A step toward precision medicine
3
3D-printed contact lenses offer patient-specific fit in 20 minutes
4
Atropine, aspherical lenses enter trial for childhood myopia
5






















